Skip to main content
Caplight Logo









Vasa Therapeutics

Vasa Therapeutics

Private
Encinitas, CaliforniaHealthcare & Life Scienceshttps://vasatherapeutics.com/

Last Round

Seed

Jan 3, 2024

Total Funding Raised

$11M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Vasa Therapeutics is a biopharmaceutical company that discovers and develops therapeutics targeting the pathophysiology of cardiovascular aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

biotechnologydrug discoveryCAMKII inhibitorscardiovascular diseasemetabolic diseaseAI drug discoveryin silico drug designmedicinal chemistrybiotech R&Dpharmaceutical licensingpreclinical developmentAI-driven therapeuticscomputational biologysmall molecule inhibitorsbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vasa Therapeutics Comparables

Compare Vasa Therapeutics with similar companies based on industry and business-model similarity.

Vasa Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardiaTec
88%
Antlia Bioscience, Inc.
73%
POLYGON Therapeutics
72%

Vasa Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 3, 2024

Key People

Founding team and executive leadership

Artur Plonowski

CEO and Co-Founder

Founding Team

Michael F. Geremia

CFO

Executive Team

Vasa Therapeutics Investors

Notable investors and investment history

Vasa Therapeutics investors
InvestorRounds
SeedFolioSeed
Orphinic Scientific SASeed
NuFundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Partnered with Eli Lilly's 'tunelab' for AI/ML platform.

  • Feb 12, 2026

    Attended the 36th Annual Oppenheimer Life Sciences Conference.

Vasa Therapeutics Filings

Explore SEC and related filing metadata, where available.

Vasa Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vasa Therapeutics's valuation, stock price, and market status.

Is Vasa Therapeutics a public or private company?

Vasa Therapeutics is a private company.

What is the current stock price of Vasa Therapeutics?

Vasa Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Vasa Therapeutics worth (valuation)?

Valuation information for Vasa Therapeutics is not publicly available.

Can I buy Vasa Therapeutics stock?

Vasa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vasa Therapeutics's last funding round?

Vasa Therapeutics's most recent funding round was Seed on January 3, 2024.

Who are the main investors in Vasa Therapeutics?

Key investors in Vasa Therapeutics include Orphinic Scientific SA.

Will Vasa Therapeutics IPO soon?

No public IPO plans have been announced for Vasa Therapeutics.

How can I track Vasa Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vasa Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEncinitas, California
Employee Range14
Year Founded2019
Last FundingJan 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?